PLx Pharma (PLXP) PT Raised to $12 at JMP Securities, Following Clinical Update
Tweet
Share
E-mailGet Alerts PLXP Hot Sheet
Price: $0.09 --0%
Rating Summary:
3 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 17
Rating Summary:
3 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 17
Join SI Premium – FREE
JMP Securities analyst Jason N. Butler raised the price target on PLx Pharma (NASDAQ: PLXP) to $12.00 (from $9.00) while maintaining a Market Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AEON Biopharma, Inc (AEON) PT Lowered to $1.20 at H.C. Wainwright
- Burlington Stores (BURL) PT Raised to $440 at UBS
- JBS SA (JBS) PT Lowered to $17 at Stephens
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
